Published 27 March 2009, doi:10.1136/bmj.b919
Cite this as: BMJ 2009;338:b919

Research

Neonatal vitamin A supplementation for prevention of mortality and morbidity in infancy: systematic review of randomised controlled trials

¹ Department of Paediatrics and Clinical Epidemiology, Sitaram Bhartia Institute of Science and Research, B-16 Qutab Institutional Area, New Delhi 110016, India

Objective To evaluate the effect of neonatal vitamin A supplementation on infant mortality, morbidity and early adverse effects.

Design Systematic review, meta-analysis, and meta-regression of randomised controlled trials.

Data sources Electronic databases and hand search of reviews; abstracts and proceedings of conferences.

Review methods Randomised or quasi-randomised or cluster randomised, placebo controlled trials evaluating the effect of prophylactic, neonatal (<1 month) supplementation with synthetic vitamin A on mortality or morbidity within infancy (<1 year), and early adverse effects (7 days).

Results The six included trials were from developing countries. There was no convincing evidence of a reduced risk of mortality during infancy (relative risk 0.92, 95% confidence interval 0.75 to 1.12, P=0.393 random effect; I²=54.1%) or of an increase in early adverse effects including bulging fontanelle (1.16, 0.81 to 1.65, P=0.418; I²=65.3%). No variable emerged as a significant predictor of mortality, but data for important risk groups (high maternal night blindness prevalence and low birth weights) were restricted. Limited data (from one to four trials) did not indicate a reduced risk of mortality during the neonatal period (0.90, 0.75 to 1.08, P=0.270; I²=0%), cause specific mortality, common morbidities (diarrhoea and others), and admission to hospital. There was, however, evidence of an increased risk of acute respiratory infection and a reduced risk of clinic visits.

Conclusions There is no convincing evidence of a reduced risk of mortality and possibly morbidity or of increased early adverse effects after neonatal supplementation with vitamin A. There is thus no justification for initiating such supplementation as a public health intervention in developing countries for reducing infant mortality and morbidity.

© Gogia et al 2009
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Vitamin A supplements in newborns and child survival

James M Tielsch
BMJ 2008 336: 1385-1386. [Extract] [Full Text] [PDF]

Vitamin A supplementation in infectious diseases: a meta-analysis.

P P Glasziou and D E Mackerras
BMJ 1993 306: 366-370. [Abstract] [PDF]

Childhood mortality after a high dose of vitamin A in a high risk population.

N. M. Daulaire, E. S. Starbuck, R. M. Houston, M. S. Church, T. A. Stukel, and M. R. Pandey
BMJ 1992 304: 207-210. [Abstract] [PDF]

Rapid Responses:

Read all Rapid Responses

A Central Question Not Answered: Can Newborn Vitamin A Reduce Infant Mortality in South Asia?

Keith P. West, Jr., et al.
bmj.com, 2 Apr 2009 [Full text]

Academic Nihilism and Vitamin A

Laurence E Wood
bmj.com, 4 Apr 2009 [Full text]

Vitamin A supplements in newborns in South asia

Dr.Umesh Kapil
bmj.com, 11 May 2009 [Full text]

Online poll

Find out more >>